4//SEC Filing
Reich Kristian 4
Accession 0001213900-26-002905
CIK 0001821586other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:01 PM ET
Size
5.6 KB
Accession
0001213900-26-002905
Insider Transaction Report
Form 4
Reich Kristian
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-07+520,342→ 520,342 totalExercise: $11.29Exp: 2036-01-07→ Class A ordinary shares, par value $0.0001 per share (520,342 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 520,342 of the Issuer's Class A ordinary shares, vesting in four equal annual installments on January 7, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001920553
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:01 PM ET
- Size
- 5.6 KB